Two Newark, New Jersey, attorneys say it’s inconsistent for New Jersey to have a medical marijuana program and still classify the drug among the most dangerous.
NJ.com reports a three-judge state appeals panel in Trenton agreed to release an opinion on the matter after hearing arguments from Joseph Linares and Marc Haefner of the Walsh Firm on Tuesday.
The lawyers urged the state to change its decades-old classification of marijuana as a Schedule I drug while arguing on behalf of two plaintiffs – an inmate serving a life sentence for drug trafficking and a Maple Shade teen who uses medical marijuana to help control epileptic seizures.
New Jersey state law on Schedule I drugs
The director shall place a substance in Schedule I if he finds that the substance: (1) has high potential for abuse; and (2) has no accepted medical use in treatment in the United States; or lacks accepted safety for use in treatment under medical supervision.
State Deputy Attorney General Jodi Krugman has opposed requests to alter marijuana’s classification, most recently last summer.
Drug classifications impact the severity of criminal sentences.